Journal Report

ACS MEDICINAL CHEMISTRY LETTERS

Download PDF
Journal Information
Journal Title
ACS MEDICINAL CHEMISTRY LETTERS
Publisher
AMER CHEMICAL SOC
ISSN
1948-5875
E-ISSN
1948-5875
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025 ✓
2024 ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Discovery of <i>N</i> -Acyl Pyrimidine-Biphenyl Small-Molecule PD-L1 Inhibitors that Restore T Cell Function and Suppress Tumor Growth in Breast Cancer
Vidya Jyothi Alli, Teja Nallavolu, Maresha Ramakrishna et al.
2026-11-3
DOI: 10.1021/acsmedchemlett.6c00411
Design, Synthesis, and Biological Evaluations of Constrained Ugi Adducts as Anti-JEV Agents
Priyanka, Babita Bohra, Ayush Raj et al.
2026-11-2
DOI: 10.1021/acsmedchemlett.6c00423
Synthesis and Evaluation of Mevalonate Diphosphate Analogs as Butyrophilin 3A3 Ligands
Umed Singh, Chia-Hung Christine Hsiao, David F. Wiemer et al.
2026-10-26
DOI: 10.1021/acsmedchemlett.6c00432
Novel Triazolopyrimidine Analogs as Glucosylceramide Synthase Inhibitors
Yinlong Li, Luke Rasmituth, Steven H. Liang
2026-10-24
DOI: 10.1021/acsmedchemlett.6c00537
Direct STAT6 Inhibition Converts a Cytokine Signaling Hub into a Drug Target
Anna C. Renner, Robert B. Kargbo
2026-10-23
DOI: 10.1021/acsmedchemlett.6c00530
Discovery and <i>In Vitro</i> Characterization of Macrocyclic 2-(Heteroaryl)Pyrimidine Inhibitors Targeting Wild-Type KRAS and G12D/G12V Mutants
Casey J. N. Mathison, Wei Pei, Shanshan Yan et al.
2026-10-23
DOI: 10.1021/acsmedchemlett.6c00409
Pyridazino-Indoles as Phenol Bioisosteres for Potent Inhibition of NLRP3
L. Bouché, S. Mesch, S. Steiner et al.
2026-10-22
DOI: 10.1021/acsmedchemlett.6c00422
Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory Diseases
Ram W. Sabnis
2026-10-22
DOI: 10.1021/acsmedchemlett.6c00540
Novel Compounds as NIK Inhibitors for Treating Autoimmune Diseases
Ram W. Sabnis
2026-10-22
DOI: 10.1021/acsmedchemlett.6c00558
Novel Fused Bicyclic Compounds as VRK1 Inhibitors for Treating Glioblastoma or Neuroblastoma
Ram W. Sabnis, Anika R. Sabnis
2026-10-22
DOI: 10.1021/acsmedchemlett.6c00557
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 5, 2026 01:25